Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
نویسندگان
چکیده
منابع مشابه
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
PURPOSE To investigate the 2-year outcomes of three monthly intravitreal ranibizumab injections followed by as-needed reinjections to treat polypoidal choroidal vasculopathy (PCV). METHODS Seventy-five consecutive eyes with naïve symptomatic PCV with 2 years of follow-up after treatment were studied prospectively. RESULTS The mean (±SD) numbers of injections were 4.2±1.3 that included three...
متن کاملIndividualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
BACKGROUND To investigate the third-year results of ranibizumab monotherapy for polypoidal choroidal vasculopathy (PCV) in individualized treatment regimens based on the outcomes during 2 years. METHODS One hundred seventy-two consecutive eyes of 163 prospective treatment-naïve patients with PCV were treated with three monthly intravitreal ranibizumab injections followed by as-needed reinject...
متن کاملContinuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6-month results.
AIM To evaluate the short-term efficacy and safety of monthly intravitreal injections of ranibizumab in patients with polypoidal choroidal vasculopathy (PCV) and active exudation or haemorrhage. METHODS A prospective, open-label trial of monthly intravitreal ranibizumab (0.5 mg) injections for PCV in 12 eyes of 12 patients was performed. The primary outcome measures were stabilisation of visi...
متن کاملShort-term anatomic effect of ranibizumab for polypoidal choroidal vasculopathy.
PURPOSE To assess the short-term anatomic effect of intravitreal ranibizumab for polypoidal choroidal vasculopathy. METHODS All patients had undergone a full ophthalmic examination. A monthly injection of ranibizumab was performed for 3 months. Indocyanine angiography (ICG) and optical coherence tomography (OCT) were performed 1 month after the third-month ranibizumab injection. RESULTS Pol...
متن کاملOne-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
PURPOSE To compare the 1-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy (RF-PDT) to intravitreal ranibizumab (IVR) alone for eyes with polypoidal choroidal vasculopathy (PCV). METHODS We reviewed the medical records from 47 consecutive patients with PCV (47 naïve eyes). Seventeen eyes from 17 patients had one IVR treatment combined with RF-PDT foll...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Ophthalmology
سال: 2013
ISSN: 0007-1161,1468-2079
DOI: 10.1136/bjophthalmol-2012-302652